MDSAP for Medical Devices

Updated October 26, 2024

Medical devices help clinicians deliver care, but the rules for those devices differ by country. That makes compliance expensive and repetitive. The Medical Device Single Audit Program (MDSAP) was created to reduce that burden. This article explains how MDSAP works, what it does for compliance, where implementation gets hard, and how it may shape future regulation.

Key Takeaways

• MDSAP unifies medical device unifies audits for multiple regulators.
• Participating countries include the US, Canada, Brazil, Australia, Japan.
• Reduces redundant audits, saving time and resources for manufacturers.
• Promotes consistent quality management system oversight.
• MDSAP enhances patient safety through standardized requirements.
• Manufacturers must adapt internal processes for MDSAP compliance.

Understanding the MDSAP Program

MDSAP was set up to simplify international compliance for medical device manufacturers. It aligns audit procedures across participating countries, including the United States, Canada, Brazil, Australia, and Japan. MDSAP uses one standardized process to assess a manufacturer’s quality management system.

The Purpose of MDSAP

The main goal of MDSAP is to let medical device manufacturers complete a single audit that satisfies multiple regulators. That cuts duplicated work, lowers cost, and frees resources for product development.

Key Participants in MDSAP

MDSAP depends on coordination between regulatory authorities and medical device manufacturers. Participating regulators set the standard audit process and requirements. Manufacturers must meet MDSAP requirements and undergo audits by authorized auditing organizations.

A standardized audit process also gives manufacturers a clearer view of what multiple regulators expect. That makes compliance more predictable and promotes consistency across the industry.

MDSAP also supports collaboration among participating countries. By aligning audit procedures, regulators can share practices and improve their own frameworks. That exchange helps improve the safety and effectiveness of medical devices.

The Role of MDSAP in Medical Device Compliance

MDSAP helps manufacturers meet global regulatory requirements with less duplication. Its value shows up in global compliance, the audit process, and the operational benefits for manufacturers.

MDSAP’s Impact on Global Regulatory Compliance

The old model required separate audits by each regulator. That meant repeated assessments, higher costs, and more internal effort. MDSAP removes much of that duplication by allowing one audit to satisfy multiple regulatory authorities. That reduces audit fatigue and can speed time to market.

MDSAP also pushes participating countries toward more consistent safety and quality expectations. When requirements are better aligned, manufacturers can target multiple markets with less rework, and healthcare providers get devices assessed against more consistent standards.

The Process of MDSAP Auditing

The MDSAP audit process has five stages: planning, conducting, reporting, closing, and monitoring. In planning, the authorized auditing organization works with the manufacturer to define the audit scope and build the audit plan. That includes identifying applicable requirements and the documents and evidence to review.

In the conduct stage, auditors perform on-site assessments of the manufacturer’s quality management system and verify compliance. They interview staff, review records, and inspect operations to confirm that processes match regulatory requirements. This is where gaps and nonconformities are identified.

After the audit, the auditing organization issues a report with findings, observations, nonconformities, and improvement opportunities. The manufacturer then addresses the nonconformities. That may require corrective actions, procedure updates, or additional evidence.

Once corrective actions are implemented, the audit closes and ongoing compliance is monitored. Monitoring can include surveillance audits or follow-up assessments to confirm the corrective actions work.

Benefits of MDSAP for Medical Devices

MDSAP gives medical device manufacturers several practical advantages.

Streamlining International Compliance

Before MDSAP, manufacturers had to work through each country’s regulatory requirements on their own. That took significant time and resources and created a barrier to entering global markets. MDSAP provides one framework that supports compliance across multiple jurisdictions. That saves time, reduces duplicated effort, and helps manufacturers bring devices to market faster.

Reducing Audit Time and Resources

A single MDSAP audit replaces multiple separate audits. That cuts redundant assessments and reduces the administrative overhead tied to scheduling, preparation, and follow-up. Manufacturers can put that time back into product quality, R&D, and other business-critical work. It also improves efficiency and competitiveness.

Enhancing Patient Safety

A core MDSAP objective is better patient safety through stronger quality oversight. The audit process requires manufacturers to show compliance with internationally recognized quality management system requirements. That includes design controls, risk management, and post-market surveillance processes. Meeting those requirements helps reduce device failures, adverse events, and other safety issues.

Challenges in Implementing MDSAP

MDSAP has clear benefits, but implementation is not frictionless.

Overcoming Initial Implementation Hurdles

Manufacturers often need to adjust existing quality management systems to meet MDSAP requirements. That can take time and effort. It may require updating documentation, training staff, and adding controls to close compliance gaps.

Internal communication is another common problem. Organizations need clear communication so each team understands what changed and what they own. That gets harder in larger companies with multiple departments and sites.

Addressing Common Concerns with MDSAP

Some manufacturers worry about stricter audit scrutiny and whether auditing organizations are competent. Those concerns are common, but participating regulatory authorities maintain oversight of authorized auditing organizations to verify consistency and competence.

Regulators assess the auditing organizations’ experience, expertise, and compliance with international standards. They also audit those organizations on an ongoing basis. That oversight helps preserve the integrity of the assessment process.

Manufacturers can also reduce friction by engaging early with the auditing organization. Direct communication helps clarify expectations, answer process questions, and improve audit readiness.

Future of MDSAP in the Medical Device Industry

MDSAP has already changed how many manufacturers approach international compliance.

Predicted Trends for MDSAP

As the medical device industry changes, MDSAP will likely become more prominent. More countries may join, extending the program’s reach and expanding the use of a common compliance framework.

Technology may also change how audits are performed. Artificial intelligence and data analytics could make audits faster and more targeted. For example, automated analysis could help identify risks and improvement areas earlier, which would improve audit efficiency.

MDSAP’s Potential Impact on Future Regulations

MDSAP’s success in aligning requirements across multiple countries may influence how other industries approach global compliance. It offers a working model for regulators and industry groups trying to reduce duplication across borders.

The program also shows the value of direct collaboration between regulators and manufacturers. That kind of coordination will matter more as technologies change and regulations need to keep pace. MDSAP creates a structure for that ongoing dialogue.

Conclusion

MDSAP simplifies international compliance for medical device manufacturers by aligning audit procedures and requirements across participating countries. It reduces duplicate audits, lowers resource demands, and gives manufacturers a more efficient path to global compliance. It also supports better consistency in quality oversight and patient safety.

Implementation still takes work. Manufacturers may need to update quality systems, train teams, and address audit concerns. But with planning and support, those challenges are manageable.

MDSAP will likely keep growing in reach and influence. As more regulators align around shared expectations and audit models, the medical device industry gets a more efficient compliance path and patients benefit from stronger oversight.

Medical Device Testing FAQs

How do I get a quote for a medical device test from Blue Goat?

Please schedule a 30-minute Discovery Session with us so we can best understand your objectives.

What insights does Blue Goat Cyber provide related to software testing in the healthcare industry?

Blue Goat Cyber provides several key insights related to software testing in the healthcare industry, focusing on comprehensive methods for various software and medical devices. They emphasize the importance of governance in cybersecurity programs, ensuring that medical software complies with regulatory standards like FDA guidelines and HIPAA. Additionally, Blue Goat Cyber stresses proactive risk mitigation, including strategies for identifying and managing potential vulnerabilities in healthcare software. Their approach also includes educating healthcare organizations on cybersecurity risks and best practices, advocating for a culture of awareness and proactive security measures in the industry.

What are the security requirements that medical device applicants must now meet?

The U.S. Food and Drug Administration (FDA) has established specific cybersecurity requirements that medical device manufacturers must meet. These include:

1. Secure Product Development Lifecycle: Manufacturers are required to implement a secure product development lifecycle. This involves reducing the number and severity of vulnerabilities throughout the entire lifecycle of their devices, from design and development to distribution, deployment, and maintenance​.

2. Threat Modeling and Post-Market Vulnerability Management: Manufacturers must conduct threat modeling and outline plans for addressing post-market vulnerabilities. This includes patching and software updates to respond to potential security issues​​​.

3. Coordinated Disclosure of Exploits and Software Bill of Materials: Details of the methods for coordinated disclosure of exploits must be included. Manufacturers must also supply a software bill of materials (SBOM) that details all third-party commercial, open-source, and off-the-shelf software components used in their devices​​​.

4. Process and Procedures for Postmarket Updates and Patches: Companies must provide details on the processes and procedures for releasing postmarket updates and patches that address security issues. This includes regular updates and out-of-band patches for critical vulnerabilities​​.

These requirements apply to "cyber devices," which are defined as any devices that run software, have the ability to connect to the internet, and could be vulnerable to cyber threats. As of October 1, 2023, the FDA's refuse-to-accept policy comes into force for pre-market submissions that lack the required cybersecurity information​​​​.

Medical device manufacturers should familiarize themselves with the FDA's updated guidance document, "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions," to ensure their products meet the required cybersecurity standards. Failure to meet these requirements could result in the FDA rejecting pre-market submissions​​.

What new policy has the FDA announced for medical device manufacturers?

According to the recent announcement by the FDA, medical device manufacturers are now required to adhere to a new policy related to cybersecurity. Under this policy, all new applicants for medical devices must submit a comprehensive plan that outlines how they will actively monitor, identify, and address potential cybersecurity issues. This plan should also include steps to ensure that the device in question is adequately protected.

Additionally, the FDA now mandates that applicants establish a reliable process that reasonably assures the device's security. This includes taking necessary measures to make security updates and patches available regularly and in critical situations. The applicants must also provide the FDA with a detailed software bill of materials, encompassing any open-source or other software utilized in their devices.

Overall, this new policy enacted by the FDA emphasizes the importance of cybersecurity in medical devices and aims to ensure that manufacturers take appropriate measures to safeguard patient safety and protect against potential cyber threats.

What is Blue Goat's methodology for medical device cybersecurity assessment for FDA compliance?

Blue Goat uses a two-step Assessment Evolution test/retest approach for optimal outcomes. Within each Evolution, in addition to the actual medical device assessment and testing components, we dedicate access to our cybersecurity team for report clarification and knowledge exchange, assisting in your understanding of the test findings and the remediation strategies.

Post-remediation of Evolution 1, we will again conduct the cybersecurity assessment and penetration test to assess the efficacy of addressing identified vulnerabilities. This second set of reporting demonstrates a more secure posture and, therefore, a more impactful Letter of Attestation.

Our overall medical device security assessment and testing process involves four high-level phases:

1. Discovery
2. Security Boundary Definition
3. Security Risk Assessment
4. Mitigation Strategy

Medical Device Assessment Evolution 1

1. Preparation (Offsite). Before we travel to your facility, we prepare for the onsite visit. Our preparation  consists of Discovery, such as a review of the following:

• Design documents
• Data flow diagrams
• Use cases
• Traceability matrix
• Security architecture
• User manuals
• Admin/maintenance manuals
• Installation procedures and guidance
• Risk assessment
• Hazard analysis
• Source code
• Total Product Life Cycle (TPLC) documentation
• Product photos
• Any other relevant device documentation

We intend to get familiar with your product, formulate a plan of action, and develop the Test Plan and Test Cass before our onsite visit. This allows us to optimize our time onsite.

2. T esting (Onsite or at Blue Goat's facility). We travel to your facility to perform the cybersecurity assessment and penetration test against your medical device/system. Testing can also be performed at Blue Goat’s facility if you ship the equipment to us. Our testing consists of identifying all entry points into the system, such as Ethernet, Fiber, WiFi, USB, BTLE, Serial, and HDMI. We assess vulnerabilities associated with each entry point and the exploitation of initial and subsequent vulnerabilities. Any critical findings discovered will immediately be brought to your attention. In addition, due to the nature of our engagement, we can share our test results with you daily as an end-of-day update.

3. Reporting (Offsite). At the end of testing, we generate a medical device cybersecurity assessment and penetration test report that ranks our findings based on criticality. The report will include step-by-step exploitation steps, described with screenshots. The report also includes remediation guidance for each finding.

4. Report Presentation (Offsite). Once the report is completed, we securely send it to you and review it via Zoom.

Between Evolution 1 and Evolution 2, you will work on fixing issues identified in Evolution 1.

Medical Device Assessment Evolution 2​

When you are ready for us to retest the medical device, we repeat the applicable steps of Evolution 1 in Evolution 2. This will be completed onsite at Blue Goat or your facility.

At the end of Evolution 2, we will generate a Letter of Attestation that summarizes the medical device's scope, findings, and overall risk rating. The Letter of Attestation is intended to be shared with clients, auditors, regulators, etc.

What is the goal of a penetration test against a medical device?

Blue Goat understands the importance of securing your wired or wireless medical devices and protecting your business from cybercriminals. We aim to assess the cybersecurity posture of your devices thoroughly so we can identify vulnerabilities and weaknesses in their networks and infrastructure. By conducting a penetration test, we help protect patient safety and reduce organizational risk.

During the penetration test, our team evaluates the security defenses of your medical devices and looks for possible entry points for cyberattacks. We examine hardware, software, peripherals, and other input/output systems. Our experts fuzz, analyze, and test each area for flaws that could compromise patient care or device integrity.

We also pay close attention to common vulnerabilities and exposures (CVEs) seen in medical devices. We assess whether kiosked applications can be bypassed and whether attackers could gain access to underlying operating systems. That work can take hours or days to uncover a chain of flaws that bypasses those controls.

We also inspect the physical device for alternate ports such as JTAG, UART, other unprotected ports, additional USB ports, and accessible hard drives.

Our assessments also include forensics and post-exploitation activity. We detonate payloads, pivot, and adjust operating systems to simulate real-world conditions that could affect patient care. We also reverse engineer proprietary binaries and programs, searching for sensitive keys to determine whether encryption uses static or dynamically created keys.

This penetration test gives you a full view of your medical device’s vulnerabilities and weaknesses. Our findings let us provide detailed recommendations for patching and strengthening defenses, improving patient safety, and reducing risk to your organization.

What is AAMI TIR57?

AAMI TIR57 is a technical information report focused on the principles for medical device security-risk management. It's a guideline from the Association for the Advancement of Medical Instrumentation (AAMI), an organization well-known for its work in medical devices.

Overview

AAMI TIR57, titled "Principles for medical device security-Risk management," offers a structured approach to managing cybersecurity risks in medical devices. This is particularly important because medical devices, like any other connected technology, can be vulnerable to cyber threats. This report provides guidance on implementing security measures throughout a device's lifecycle, from design and development to decommissioning.

The "Why"

TIR57 matters because it focuses on patient safety and data security. As medical devices become more interconnected and software-dependent, they become more exposed to cyber threats. Those threats can affect device functionality and lead to patient harm. TIR57 helps manufacturers and healthcare providers reduce that risk by establishing sound security practices.

Examples and Case Studies

Say a hospital uses networked medical devices like heart rate monitors or insulin pumps. These devices are critical for patient care. If they are hacked because of weak security, the result could be anything from a data breach to a life-threatening event. Applying the principles of AAMI TIR57, such as performing risk assessments and building cybersecurity into device design, helps prevent that.

For Blue Goat Cyber, understanding and applying AAMI TIR57 can be a major value proposition. It means you can offer services aligned with these standards and assure clients that their medical device security is being managed effectively. That includes conducting risk assessments, advising on secure device design, and offering ongoing security support.

Connecting the Dots

In this field, AAMI TIR57 is more than a guideline. It is a framework for protecting the security and safety of medical devices, which is a core part of healthcare cybersecurity. By integrating these principles into your services, Blue Goat Cyber positions itself as a knowledgeable provider of medical device security.

Understanding and applying AAMI TIR57 can also help when speaking with cybersecurity decision-makers in healthcare. They need experts who understand both cybersecurity and the specific risks tied to medical devices. Expertise here can be a real differentiator.

What is a Cybersecurity Bill of Materials (CBOM)?

A Cybersecurity Bill of Materials (CBOM) is an essential requirement enforced by the FDA from March 29, 2023, onwards for medical devices. It mandates medical device manufacturers to provide a comprehensive and accurate list of software and hardware components used in their devices, including any third-party software and open source components. This list, known as the CBOM, serves as a self-attestation by manufacturers, indicating the accuracy and completeness of the components used in their medical devices. One critical aspect of the CBOM is the inclusion of a Software Bill of Materials (SBOM), which ensures complete transparency regarding software components used in medical devices. Given the crucial nature of medical devices and the potential risks associated with cybersecurity, having a comprehensive and accurate SBOM is particularly vital in maintaining the security and integrity of these devices.

How can Blue Goat help in generating accurate SBOMs?

Blue Goat has a long-standing record of providing reliable and precise Software Bill of Materials (SBOMs) for its clients for over ten years. We have developed sophisticated tools that enable us to identify components, even at the snippet level, accurately. With our advanced string search algorithms, we can effectively detect all third-party and commercial components. Additionally, Blue Goat offers a comprehensive SBOM-as-a-service solution, which ensures that clients receive complete and accurate SBOMs in standard formats such as SPDX and CDX, which comply with the FDA's requirements. Moreover, Blue Goat can validate internally generated SBOMs or those created by their software supply chain partners, guaranteeing alignment with FDA regulations. By leveraging out expertise and tools, Blue Goat can play a crucial role in assisting organizations to generate reliable and accurate SBOMs.

What's the difference in a CBOM and SBOM?

The terms "Cybersecurity Bill of Materials" (CBOM) and "Software Bill of Materials" (SBOM) are related concepts in the realm of cybersecurity and software management, often used within the context of improving transparency and security of software products and systems, including medical devices. The primary distinction between the two lies in their scope and specific focus:

1. Software Bill of Materials (SBOM): An SBOM is a detailed list that provides an inventory of all components, libraries, and modules that make up a piece of software, including both open-source and proprietary elements. The primary purpose of an SBOM is to give users (which can include end-users, developers, and security professionals) a clear understanding of what software is running in their environment. This transparency is crucial for vulnerability management, license management, and security analysis, enabling users to identify potential security risks, comply with licensing requirements, and perform effective patch management.

2. Cybersecurity Bill of Materials (CBOM): A CBOM extends the concept of an SBOM by including not just software components but also detailing hardware components, network dependencies, and any other elements critical to understanding the cybersecurity posture of a device or system. The CBOM is particularly relevant in contexts where the security of the entire ecosystem, including physical components and network interactions, is critical. For example, understanding the full spectrum of components and dependencies in medical devices or industrial control systems is essential for assessing vulnerabilities, potential attack vectors, and overall system security.

In essence, while an SBOM is specifically focused on software components, a CBOM provides a broader view that encompasses all elements relevant to cybersecurity. Both are tools aimed at enhancing the security and manageability of software and systems, but they do so from slightly different angles. The adoption of SBOMs and CBOMs is encouraged by various cybersecurity frameworks and standards to promote transparency and facilitate better risk management practices.

What is the significance of SBOMs and SPDX in the present and future?

March 29, 2023, marked a significant milestone as the FDA began enforcing cybersecurity requirements for medical devices, urging manufacturers to comply with a Cybersecurity Bill of Materials (CBOM). A crucial element of the CBOM is the inclusion of a Software Bill of Materials (SBOM), which outlines the comprehensive list of software and hardware components utilized within medical devices. This encompasses not only internally developed software but also third-party software and open-source components.

The significance of SBOMs lies in their ability to enhance transparency and accountability in the supply chain of medical devices. By mandating medical device manufacturers to self-attest to the accuracy of their SBOMs, regulators can obtain a holistic view of the components employed in the production of these devices. This promotes better assessment and management of potential security vulnerabilities.

One of the recognized standards for SBOMs is the Software Package Data Exchange (SPDX) format. SPDX provides a consistent and standardized way to document and share SBOMs, enabling efficient communication between various stakeholders, including manufacturers, regulators, healthcare providers, and consumers. This universal language supports interoperability and simplifies the evaluation of SBOMs by allowing for easy comparison and analysis.

The significance of SBOMs and SPDX in the present and future lies in their ability to fortify cybersecurity practices and enhance transparency across industries, not just within the medical field. As highlighted by the National Telecommunications and Information Administration (NTIA), the implementation of SBOMs should extend beyond medical devices, becoming a common practice in other sectors as well. This indicates a growing recognition of the importance of understanding and managing the software components in all connected systems.

With the regulatory enforcement of SBOMs, companies across industries are actively working towards creating compliant SBOMs, with some seeking assistance from third-party providers who specialize in generating accurate and robust SBOMs. These providers, like Synopsys, offer sophisticated tools and solutions that can precisely identify software components used, including third-party and commercial components. They can also ensure that the generated SBOMs align with the specific requirements set forth by regulatory bodies, such as the FDA.

What are the additional elements required by the FDA for an SBOM?

The FDA has established additional requirements for a Software Bill of Materials (SBOM) for medical devices. In addition to the minimum elements defined by the National Telecommunications and Information Administration (NTIA), the FDA mandates including specific information. These additional elements encompass the support level, support end date, and known security vulnerabilities of the software components used in the medical devices.

While open source projects may not have designated support levels or support end dates, these additional elements largely apply to third-party or commercial components integrated within the medical device application. It is crucial to include complete and accurate SBOMs for medical devices, as they enable transparency and focus on cybersecurity.

How can Blue Goat Cyber help ensure that medical device software complies with required standards and regulations?

Blue Goat understands the need for compliance in medical device software. Our team knows the security process and helps protect organizations from costly and dangerous attacks. With experience across multiple types of testing, we can address the specific requirements of your device.

We also take compliance seriously. Our team helps you work through the regulatory environment, including the guidelines set by the FDA. We understand the pressure around release timelines and can help you move through the steps needed to meet required standards and regulations.

With Blue Goat involved, your medical device software can meet required compliance standards and give you more confidence in the safety and effectiveness of your product.

What tools does Blue Goat use for testing software for medical devices?

Blue Goat Cyber uses a combination of Static Application Security Testing (SAST) and Dynamic Application Security Testing (DAST) for medical device software testing. SAST involves analyzing the source code to identify vulnerabilities, while DAST tests the running application to find security issues. Both methods are critical for ensuring the security of medical devices, which handle sensitive data and are subject to strict FDA regulations and HIPAA guidelines. Blue Goat Cyber's approach addresses unique concerns related to medical devices, such as compliance with evolving security standards and the protection of critical patient information.

In addition to SAST and DAST, Blue Goat Cyber also incorporates penetration testing and vulnerability assessment tools for comprehensive medical device software testing. Penetration testing tools simulate real-world cyberattacks to identify potential security breaches, while vulnerability testing tools systematically scan for known vulnerabilities. Together, these methods provide a framework for ensuring the security and compliance of medical devices, addressing unique challenges such as critical functionality, data sensitivity, and regulatory standards like FDA clearance and HIPAA compliance​.

What is some background on medical device vulnerabilities?

Over the past few years, the Internet of Things (IoT), coupled with the widespread use of Information Technology, has created a larger attack surface where rapid solution development and added functionality often take priority over security. For example, attackers once disrupted most U.S. internet activity using 61 default IoT usernames and passwords. Consumers failed to change them before activating their devices, effectively turning those devices into participants in one of the largest Distributed Denial of Service (DDoS) attacks in history.

The healthcare industry is rapidly adopting IoT devices, often called the Internet of Medical Things (IoMT), to improve patient safety and healthcare delivery. From medication administration to remote sensor monitoring, embedded medical devices are improving care and increasing interaction with providers. But when security is ignored in the design phase, that risk can turn into real-world harm.

The consequences became clear in 2017 when researchers acquired equipment costing from $15 to $3,000 and intercepted the radio frequencies from cardiac devices. They were then able to reprogram the devices, alter a patient’s heartbeat, and drain the battery. As a result, the FDA recalled almost 500,000 pacemakers and required in-person firmware updates. Researchers have shown similar capabilities on infusion pumps and MRI systems.

Non-networked medical devices may carry even higher risk. Ease of access and the availability of RFID cloners contribute to weak physical security. In 2018, researchers showed they could emulate and alter a patient’s vital signs in real time using an electrocardiogram simulator bought on eBay for $100.

In late 2018, the Department of Health and Human Services Office of the Inspector General (IG) criticized FDA procedures for assessing post-market cybersecurity risk in medical devices. To strengthen the FDA's core mission “to ensure there is a reasonable assurance that medical devices legally marketed in the United States are safe and effective for their intended uses,” they outlined ongoing efforts to improve medical device security.

According to the FDA, “Healthcare Delivery Organizations (HDOs) are responsible for implementing devices on their networks and may need to patch or change devices and/or supporting infrastructure to reduce security risks. Recognizing that changes require a risk assessment, the FDA recommends working closely with medical device manufacturers to communicate necessary changes.”

Blue Goat can help HDOs transfer that risk by evaluating the cybersecurity posture on your wired or wireless medical devices.

Contact us today and inquire about our full-range penetration testing.

We can significantly increase your patient’s safety while reducing your organization’s risk.

What are some reasons for the lack of security in many medical devices?

The lack of security in many medical devices can be traced to several factors. One is the growing scrutiny over device vulnerabilities, which pushed regulators like the FDA to reassess cybersecurity requirements. An FBI report found that 53% of digital medical devices and internet-connected products had critical vulnerabilities, exposing patients and providers to serious risk. Many of those weaknesses were tied to unpatched and outdated devices. Research also suggests that 88% of healthcare cyberattacks involved an IoMT device, which shows how exposed these environments are.

Weak security controls have been a long-running problem. Many devices were designed to perform medical functions first, with security added later or not added at all. Those bolted-on controls have repeatedly proven inadequate. Another issue was the lack of mandatory requirements and accountability in the past, which encouraged a lax approach to security. That is changing. New regulations and the risk of costly fines have made it clear that ignoring security is no longer acceptable.

What is the purpose of the new cybersecurity regulations implemented by the FDA?

The FDA's new cybersecurity regulations were put in place to improve the security of medical devices. Section 524B (c) defines which devices fall within scope. Under that section, a device is covered if it includes software that is validated, installed, or authorized by the sponsor, or within it. The device must also be able to connect to the internet and have technological characteristics validated, installed, or authorized by the sponsor. That definition highlights the exposure of these devices to cyber threats. The purpose of these regulations is to address those vulnerabilities and create stronger accountability for medical device manufacturers. By requiring compliance and introducing potentially costly fines for non-compliance, the FDA is signaling that these rules are meant to have a real effect on device security. This shift moves the industry away from the old voluntary approach and makes clear that weak cybersecurity practices are no longer acceptable.

What testing needs can Blue Goat Cyber cover?

Blue Goat Cyber can cover a wide range of testing needs. Our expertise includes penetration testing, network penetration testing, web application penetration testing, API penetration testing, HIPAA penetration testing, SOC 2 penetration testing, PCI penetration testing, application penetration testing, internal penetration testing, black box penetration testing, gray box penetration testing, white box penetration testing, and mobile application penetration testing.

We also offer specialized services for the testing needs of medical device software. Our healthcare testing professionals verify the quality of medical device software requirements and perform testing at the API, integration, and system levels. With a focus on security, we assess whether the software architecture can withstand vulnerabilities.

To improve the reliability and security of medical device software, our team performs software code review and code analysis. We also conduct user acceptance testing to confirm the software meets usability requirements for healthcare professionals and end users.

Our compliance experts, including FDA and HIPAA specialists, work with clients to help make sure medical device software meets required standards and regulations. With detailed reporting and test documentation aligned with ISO 13485 and ISO/IEC/IEEE 29119-3:2021, we provide transparency into our testing activities.

In addition to healthcare and medical device software testing, we offer medical device cybersecurity, cyber threat awareness training, enterprise cybersecurity audit, static application security testing (SAST), dynamic application security testing (DAST), vulnerability assessment services, CISO-as-a-Service, physical security assessment, phishing services, and HIPAA security risk analysis (HIPAA SRA).

At Blue Goat Cyber, we focus on delivering comprehensive and reliable solutions across a broad range of testing needs.

How can Blue Goat help organizations protect their assets and networks and produce safer medical devices?

Blue Goat offers solutions to help organizations protect assets and networks while producing safer medical devices. Organizations that work with Blue Goat gain access to services and expertise that support a strong security testing program.

Through experience in cybersecurity, Blue Goat can assess current security measures, identify vulnerabilities and risks in network infrastructure, and recommend strategies to improve the overall security posture. Those steps help organizations better protect assets and networks from cyber threats.

Blue Goat also provides guidance tailored to the healthcare industry to support the development of safer medical devices. The team understands the specific security challenges medical device manufacturers face and can recommend ways to reduce those risks. Their experience in medical device security can also help organizations align with FDA regulatory requirements and industry best practices, reducing the chance of vulnerabilities and data breaches.

What is the FDA's new requirement for connected medical devices?

The FDA introduced a new requirement for connected medical devices that took effect on March 29, 2023. The requirement focuses on cybersecurity and is intended to improve the safety and security of these devices. One part of the requirement is the implementation of a Cybersecurity Bill of Materials (CBOM).

Under the CBOM, manufacturers of medical devices must attest to the accuracy of a comprehensive list of software and hardware components used in their devices. That list must include components developed by the manufacturer as well as any third-party software and open-source components included in the device.

The FDA also emphasizes the importance of a Software Bill of Materials (SBOM) within the CBOM framework. An SBOM is important for connected medical devices because it provides a complete and accurate inventory of software components. That supports better tracking of vulnerabilities and a faster response to cybersecurity incidents.

By enforcing this requirement, the FDA is pushing manufacturers to treat cybersecurity as a core part of the development and maintenance of connected medical devices. The goal is to improve the overall safety and security of those devices for healthcare professionals and patients.

How can cybersecurity vulnerabilities in medical devices lead to patient data breaches?

Patient Monitors: Devices that monitor vital signs like heart rate and blood pressure are vulnerable to data interception and manipulation, which creates serious risk to patient data security. Attackers can exploit these weaknesses to intercept or alter the data being collected. That can lead to misdiagnosis or delayed treatment.

MRI Machines: MRI machines are central to diagnostic imaging, but they are still exposed to cybersecurity threats. Attacks against these systems can disrupt operation, produce incorrect imaging data, or cause complete failure. That can affect diagnosis and treatment planning.

Radiation Therapy Systems: If radiation therapy systems are hacked, attackers may alter controls and cause incorrect radiation doses. That can lead to under-treatment or dangerously high exposure.

Diagnostic and Imaging Equipment: Devices such as CT scanners and ultrasound machines can also be compromised. If that happens, they may produce false diagnostic information, which can drive incorrect treatment decisions.

Surgical Robots: Surgical robots rely on precise controls. Unauthorized access or manipulation can cause loss of control or altered movement during surgery, creating direct patient safety risk.

Defibrillators: External defibrillators can also be affected by cybersecurity issues. In an attack, a defibrillator’s shocks could be disrupted or its battery drained, making the device fail during an emergency.

Hospital Networking Equipment: Hospital networks are not medical devices themselves, but they are critical to the operation of connected devices. A network breach can disrupt device function and expose patient data across the environment.

These vulnerabilities show why healthcare needs strong cybersecurity controls. Up-to-date software, encryption, and strong password practices are basic requirements for protecting patient data and keeping medical devices operating safely.

What are the consequences of cyberattacks on medical devices?

Cyberattacks on medical devices can directly affect patient safety and create serious problems for healthcare institutions. Interference with device operation can lead to incorrect treatment and severe health consequences. These incidents also damage trust in both the devices and the institutions using them.

Recovery can be expensive and slow. It may involve recalls, software updates, and legal exposure. Those steps are often necessary to address the exploited weaknesses and prevent repeat incidents. Healthcare institutions need strong cybersecurity controls to protect connected medical devices and patient health.

There is also the risk that attackers gain remote control of medical devices. That could let them alter settings, deliver the wrong medication dose, or disrupt life-support systems. The risk is obvious and potentially life-threatening.

The medical field needs to treat security as part of patient safety. Reducing cyber risk, protecting device integrity, and maintaining patient trust all depend on a more proactive security posture.

What are networked medical devices and why is cybersecurity important for them?

Networked medical devices are connected devices used in healthcare settings, often relying on wireless technologies. These include insulin pumps, pacemakers, infusion pumps, patient monitors, MRI machines, and others. They help clinicians monitor and manage patients remotely and support efficient, less invasive care.

That same connectivity creates security risk. If these devices are compromised, attackers can affect patient safety and potentially cause severe harm or death. The need for stronger cybersecurity in healthcare technology is clear from multiple high-profile examples of medical device hacking.

For example, insulin pumps have been manipulated remotely, exposing patients to the risk of insulin overdose. Pacemakers have had vulnerabilities that could let attackers alter heart rhythms or drain batteries. The WannaCry ransomware attack on the UK's National Health Service showed how cyberattacks on hospital networks can also disrupt patient care indirectly.

These examples show why strong security protocols, regular software updates, and close monitoring matter. Healthcare providers need those controls to protect patients and maintain trust in connected medical devices.

What recommendations are given to prevent medjacking and secure networked devices?

To prevent medjacking and ensure the security of networked devices, the following recommendations are provided:

1. Promptly address existing devices: Take immediate action to remediate any potential infections on your networked devices.

2. Swiftly implement software/hardware fixes: Develop a strategic plan to efficiently integrate and deploy the necessary updates and fixes provided by medical device manufacturers.

3. Seek expert consultation: Engage competent HIPAA consultants to evaluate and assess your compliance program, providing on-site guidance and expertise. If needed, request a quote for a thorough HIPAA audit.

4. Prioritize cybersecurity-minded vendors: Evaluate medical device vendors based on their commitment to cybersecurity. Choose vendors that allow you to modify passwords, offer regular updates, and are willing to conduct quarterly reviews with you.

5. Manage device access: Implement strict access control measures, particularly through USB ports. Consider utilizing one-way memory sticks to prevent the spread of infections among similar devices.

6. Establish secure network zones: Isolate devices within dedicated, secure network zones. Protect them further by implementing an internal firewall that only permits access to specific services and authorized IP addresses.

7. Address end-of-life for medical devices: Regularly assess the efficacy and longevity of your medical devices. Dispose of devices that are no longer supported by manufacturers or are unable to handle malware effectively. Prior to disposal, ensure the secure wiping or destruction of any patient data stored on the devices.

By following these recommendations, you can significantly enhance the prevention of medjacking incidents and strengthen the overall security of your networked devices.

Why don't traditional cyber defense tools work with medical devices?

Traditional cyber defense tools are not compatible with network connected medical devices for several reasons. First, these devices often lack the infrastructure needed to support security tools. Unlike standard computers or mobile devices, medical devices often have limited processing power, memory, and storage. That makes resource-heavy security software impractical or impossible to run.

Also, software modifications to medical devices may be viewed as tampering and may affect compliance with regulations set by the FDA. The FDA has emphasized the need for manufacturers to build in adequate security measures, but restrictions on post-production changes make that difficult.

Traditional security tools were also built for more conventional systems and networks. They may not be designed for the specific vulnerabilities and quirks of medical devices. As a result, they may fail to identify or reduce threats aimed at those systems.

Because medical devices are safety-critical, manufacturers need to integrate security directly into design and production rather than relying on standard post-deployment tools.

Who is responsible for maintaining security within medical devices?

Maintaining security within medical devices is the responsibility of manufacturers. The FDA emphasizes that manufacturers are required to stay diligent in identifying and addressing risks and hazards associated with their devices, including those related to cybersecurity. However, it is noted that not all manufacturers take this responsibility seriously.

What types of medical devices are at the highest risk of being hacked?

The types of medical devices that are most vulnerable to hacking are stationary devices. While the idea of implanted medical devices being hacked is alarming, the main motive for most attackers is financial gain, not terrorism. Cybercriminals usually target stationary devices because they offer the greatest opportunity to steal valuable patient data at scale.

What is medjacking and how does it pose a threat to healthcare organizations?

Medjacking, also known as medical device hijacking, is a serious cybersecurity problem for healthcare organizations. It involves hackers compromising networked medical devices, including consumer health monitoring devices, wearables, embedded devices, and stationary devices connected to the internet.

One main reason medjacking is such a threat is the patient health data these devices store. Stationary devices such as x-ray scanners and chemotherapy dispensing stations are especially attractive targets because they contain sensitive information. Medical data is often worth more on the black market than credit card data.

A major contributor to these vulnerabilities is that manufacturers have not always prioritized security. Many devices lack effective built-in protections, which makes them easier to compromise. The limited usefulness of traditional cyber defense tools for medical devices makes the problem worse.

Another issue is the lack of strong government action in the past. Without strict enforcement, manufacturers had less pressure to improve device security.

Patching devices that are always in use is also difficult. Healthcare organizations depend on these systems for critical functions, so applying updates can be logistically hard.

The consequences can be severe. Organizations may violate HIPAA, face legal and financial penalties, and suffer patient data breaches.

To reduce the risk of medjacking, healthcare organizations should remediate infected devices, get fixes from manufacturers, consult HIPAA experts, evaluate vendors based on cybersecurity maturity, control device access, isolate devices in secure network zones, and dispose of outdated devices properly.

What is medical device software testing?

Medical device software testing is a critical process aimed at ensuring that software embedded within or designed to control medical devices functions accurately, reliably, and in compliance with regulatory standards. This testing verifies the software's adherence to its intended functionality, user interface, integration, and overall performance requirements as dictated by medical device regulations, such as the FDA's 21 CFR Part 11 and the internationally recognized IEC 62304 standard. The objective is multifaceted, encompassing the removal of defects in software architecture and code, ensuring the software meets strict regulatory compliance, and ultimately contributing to the production of world-class, safe medical devices.

Key components of medical device software testing include:

• Functional Testing: This evaluates the software's operational aspects to ensure it performs its intended functions correctly. It involves detailed testing of the software's features and capabilities.

• Device Verification Testing: It verifies that the device as a whole, including its software, meets all specified requirements. This testing ensures that the product is designed correctly and works as expected.

• Security Testing: Given the sensitivity of medical data and the potential impact of cybersecurity threats, testing for security vulnerabilities is essential. It helps in identifying and mitigating potential security risks.

• Interoperability Testing: This ensures that the medical device can operate compatibly and safely with other systems or devices. It's crucial for devices that are part of a larger ecosystem of medical equipment.

• Usability Testing: Focused on the human-device interaction, usability testing ensures that the device can be used efficiently, effectively, and satisfactorily by the intended users.

• Performance Testing: This assesses the software's stability, speed, and scalability under various conditions. It is crucial for ensuring that the software can handle its intended workload without failure.

• Compliance Testing: Ensures the software meets all relevant regulatory and industry standards, focusing on safety, quality, and reliability requirements specific to medical devices.

Medical device software testing follows a rigorous methodology that includes planning, requirement analysis, test case development, execution of tests, and thorough documentation throughout the testing cycle. This methodology is designed to identify and address any defects or anomalies in the software architecture, code, or performance before the device reaches the market, thereby ensuring the safety and efficacy of medical devices. The process involves a combination of automated and manual testing techniques and requires a deep understanding of both the technical and regulatory aspects of medical device development.

What are common medical device vulnerabilities?

Common medical device vulnerabilities encompass a range of issues that can compromise the safety, privacy, and effectiveness of medical devices. These vulnerabilities are often related to software flaws, outdated operating systems, or insecure interfaces, which cyber attackers can exploit to gain unauthorized access, steal sensitive data, or disrupt device functionality. Some of the most prevalent vulnerabilities include:

• Insecure Network Connections: Many medical devices connect to healthcare networks via Wi-Fi or Bluetooth, making them susceptible to eavesdropping or unauthorized access if they are not properly secured.
• Outdated Software and Firmware: Devices running on outdated software or firmware are vulnerable to known exploits that have not been patched. This includes operating systems that are no longer supported by their vendors.
• Weak Authentication and Authorization Controls: Insufficient authentication mechanisms can allow unauthorized users to gain access to medical devices, potentially leading to misuse or the alteration of critical healthcare information.
• Lack of Encryption: Failure to encrypt sensitive data both at rest and in transit can expose patient health information (PHI) and other confidential data to interception and misuse.
• Third-Party Software Components: The use of vulnerable third-party software components can introduce additional risks, as device manufacturers may not always regularly update or patched these components.
• Configuration and Customization Errors: Improper configuration or customization of medical devices can leave them open to attacks. This includes default passwords never changed or security features that are disabled for convenience.
• Physical Security: Physical access to medical devices can also pose a threat, especially if devices are not adequately secured within the healthcare facility, allowing for tampering or theft.

Addressing these vulnerabilities requires a comprehensive cybersecurity strategy that includes regular software updates and patches, strong encryption methods, robust authentication and authorization controls, and vigilant monitoring of network connections. Additionally, collaboration between device manufacturers, healthcare providers, and cybersecurity professionals is essential to ensure the ongoing protection of medical devices against emerging threats.

FAQs

What is MDSAP?

MDSAP, or the Medical Device Single Audit Program, allows a single audit of a medical device manufacturer's quality management system to satisfy the regulatory requirements of multiple participating countries. This program helps reduce the burden of separate audits for each country, streamlining compliance.

Which countries participate in MDSAP?

Key participants in MDSAP include the United States (the FDA), Canada, Brazil, Australia, and Japan. These regulatory authorities collaborate to align audit procedures and requirements under the program.

How does MDSAP benefit medical device manufacturers?

MDSAP benefits manufacturers by significantly reducing the need for multiple, country-specific audits, which saves time, resources, and administrative overhead. It also facilitates quicker market access in participating countries and promotes greater consistency in quality management system expectations.

What are the challenges of implementing MDSAP?

Initial implementation challenges for MDSAP include adjusting existing quality management systems to meet updated requirements, training staff, and Ensure clear internal communication. Manufacturers may also need to address concerns about audit scrutiny and auditor competence.

How does MDSAP improve patient safety?

MDSAP enhances patient safety by requiring manufacturers to demonstrate compliance with internationally recognized quality management system requirements, including design controls, risk management, and post-market surveillance. This rigorous oversight helps reduce device failures and adverse events.

What is the FDA's role in MDSAP?

The FDA is a key participant in MDSAP, collaborating with other regulatory authorities to define and implement the program's standards. The FDA accepts MDSAP audit reports as a substitute for routine inspections, helping to streamline compliance for manufacturers seeking to market devices in the United States.